Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Toledano, 2017, The unfinished puzzle of glutathione physiological functions, an old molecule that still retains many enigmas, Antioxid Redox Signal, 27, 1127, 10.1089/ars.2017.7230

Vučetić, 2017, The central role of amino acids in cancer redox homeostasis: vulnerability points of the cancer redox code, Front Oncol, 7, 319, 10.3389/fonc.2017.00319

Pajares, 2018, Mammalian sulfur amino acid metabolism: a nexus between redox regulation, nutrition, epigenetics, and detoxification, Antioxid Redox Signal, 29, 408, 10.1089/ars.2017.7237

Combs, 2019, The non-essential amino acid cysteine becomes essential for tumor proliferation and survival, Cancers (Basel), 11, 678, 10.3390/cancers11050678

Sahota, 2019, Cystinuria: genetic aspects, mouse models, and a new approach to therapy, Urolithiasis, 47, 57, 10.1007/s00240-018-1101-7

Kumar, 2016, Oxidative stress and huntington's disease: the good, the bad, and the ugly, J Huntingtons Dis, 5, 217, 10.3233/JHD-160205

Gu, 2016, A simple isotopic labeling method to study cysteine oxidation in alzheimer's disease: oxidized cysteine-selective dimethylation (OxcysDML), Anal Bioanal Chem, 408, 2993, 10.1007/s00216-016-9307-4

Kandasamy, 2018, Amino acid transporters revisited: new views in health and disease, Trends Biochem Sci, 43, 752, 10.1016/j.tibs.2018.05.003

Barretina, 2012, The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003

McCracken, 2013, Nutrient transporters: the achilles' heel of anabolism, Trends Endocrinol Metab, 24, 200, 10.1016/j.tem.2013.01.002

Cormerais, 2016, Genetic disruption of the multifunctional CD98/LAT1 complex demonstrates the key role of essential amino acid transport in the control of mTORC1 and tumor growth, Cancer Res, 76, 4481, 10.1158/0008-5472.CAN-15-3376

Cormerais, 2018, The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5), J Biol Chem, 293, 2877, 10.1074/jbc.RA117.001342

Ishimoto, 2011, CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc- and thereby promotes tumor growth, Cancer Cell, 19, 387, 10.1016/j.ccr.2011.01.038

Müller, 2019, CD44 regulates epigenetic plasticity by mediating iron endocytosis, bioRxiv [Preprint], 10.1101/693424

Daher, 2019, Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses, Cancer Res, 79, 3877, 10.1158/0008-5472.CAN-18-3855

Sato, 1998, Induction of cystine transport via system xc– and maintenance of intracellular glutathione levels in pancreatic acinar and islet cell lines, Biochim Biophys Acta, 1414, 85, 10.1016/S0005-2736(98)00159-X

Sato, 2005, Redox imbalance in cystine/glutamate transporter-deficient mice, J Biol Chem, 280, 37423, 10.1074/jbc.M506439200

Utsunomiya-Tate, 1996, Cloning and functional characterization of a system ASC-like Na + -dependent neutral amino acid transporter, J Biol Chem, 271, 14883, 10.1074/jbc.271.25.14883

Scalise, 2015, Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter, FEBS Lett, 589, 3617, 10.1016/j.febslet.2015.10.011

Condon, 2019, Nutrient regulation of mTORC1 at a glance, J Cell Sci, 132, jcs222570, 10.1242/jcs.222570

Mossmann, 2018, mTOR signalling and cellular metabolism are mutual determinants in cancer, Nat Rev Cancer, 18, 744, 10.1038/s41568-018-0074-8

Yu, 2016, Crosstalk between cystine and glutathione is critical for the regulation of amino acid signaling pathways and ferroptosis, Sci Rep, 6, 30033, 10.1038/srep30033

Stockwell, 2017, Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease, Cell, 171, 273, 10.1016/j.cell.2017.09.021

Maurin, 2005, The GCN2 kinase biases feeding behavior to maintain amino acid homeostasis in omnivores, Cell Metab, 1, 273, 10.1016/j.cmet.2005.03.004

Dever, 2005, GCN2 whets the appetite for amino acids, Mol Cell, 18, 141, 10.1016/j.molcel.2005.03.023

Ye, 2010, The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation, EMBO J, 29, 2082, 10.1038/emboj.2010.81

Cobler, 2018, xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction, Oncotarget, 9, 32280, 10.18632/oncotarget.25794

Delaunay-Moisan, 2017, Reexamining the function of glutathione in oxidative protein folding and secretion, Antioxid Redox Signal, 27, 1178, 10.1089/ars.2017.7148

Teskey, 2018, Glutathione as a marker for human disease, Adv Clin Chem., 87141, 10.1016/bs.acc.2018.07.004

Bansal, 2018, Glutathione metabolism in cancer progression and treatment resistance, J Cell Biol, 217, 2291, 10.1083/jcb.201804161

Orlowski, 1963, γ-glutamyl-p-nitroanilide: a new convenient substrate for determination and study of l- and d-γ-glutamyltranspeptidase activities, Biochim Biophys Acta., 73, 679, 10.1016/0926-6569(63)90197-4

Lu, 2015, MRP1 and its role in anticancer drug resistance, Drug Metab Rev, 47, 406, 10.3109/03602532.2015.1105253

Pompella, 2007, γ-glutamyltransferase, redox regulation and cancer drug resistance, Curr Opin Pharmacol., 7, 360, 10.1016/j.coph.2007.04.004

Dringen, 2002, The peptide transporter pept2 mediates the uptake of the glutathione precursor cysgly in astroglia-rich primary cultures, J Neurochem, 71, 388, 10.1046/j.1471-4159.1998.71010388.x

Frey, 2007, Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of pept2 –/– mice, Physiol Genomics, 28, 301, 10.1152/physiolgenomics.00193.2006

Yang, 2006, Glutathione peroxidase and glutathione reductase activities are partially responsible for determining the susceptibility of cells to oxidative stress, Toxicology, 226, 126, 10.1016/j.tox.2006.06.008

Bannai, 1986, Role of membrane transport in metabolism and function of glutathione in mammals, J Membr Biol, 89, 1, 10.1007/BF01870891

Oestreicher, 2019, Glutathione: subcellular distribution and membrane transport, Biochem Cell Biol, 97, 270, 10.1139/bcb-2018-0189

Sasaki, 2002, Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression, J Biol Chem, 277, 44765, 10.1074/jbc.M208704200

Conrad, 2012, The oxidative stress-inducible cystine/glutamate antiporter, system x c –: cystine supplier and beyond, Amino Acids, 42, 231, 10.1007/s00726-011-0867-5

Dixon, 2012, Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042

Yin, 2011, Free radical lipid peroxidation: mechanisms and analysis, Chem Rev, 111, 5944, 10.1021/cr200084z

Shirlee Tan, 2001, Oxytosis: a novel form of programmed cell death, Curr Top Med Chem, 1, 497, 10.2174/1568026013394741

Bannai, 1988, A novel function of glutamine in cell culture: utilization of glutamine for the uptake of cystine in human fibroblasts, J Cell Physiol, 137, 360, 10.1002/jcp.1041370221

Okazaki, 2019, Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma, Cancer Sci, 110, 3453, 10.1111/cas.14182

Luo, 2018, miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma, Cell Death Differ, 25, 1457, 10.1038/s41418-017-0053-8

Xu, 2019, Molecular mechanisms of ferroptosis and its role in cancer therapy, J Cell Mol Med, 23, 4900, 10.1111/jcmm.14511

Zhang, 2019, Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model, Cell Chem Biol, 26, 623, 10.1016/j.chembiol.2019.01.008

Ji, 2018, xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression, Oncogene, 37, 5007, 10.1038/s41388-018-0307-z

Patel, 2019, Novel analogs of sulfasalazine as system x c– antiporter inhibitors: insights from the molecular modeling studies, Drug Dev Res, 80, 758, 10.1002/ddr.21557

Liang, 2019, Recent progress in ferroptosis inducers for cancer therapy, Adv Mater, 31, 1904197, 10.1002/adma.201904197

Cramer, 2017, Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth, Nat Med, 23, 120, 10.1038/nm.4232

Liu, 2020, Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance, Br J Cancer, 122, 279, 10.1038/s41416-019-0660-x

Zhu, 2019, Transsulfuration activity can support cell growth upon extracellular cysteine limitation, Cell Metab, 30, 865, 10.1016/j.cmet.2019.09.009

Leikam, 2014, Cystathionase mediates senescence evasion in melanocytes and melanoma cells, Oncogene, 33, 771, 10.1038/onc.2012.641

Griffith, 1979, Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine), J Biol Chem, 254, 7558, 10.1016/S0021-9258(18)35980-5

Cao, 2019, A genome-wide haploid genetic screen identifies regulators of glutathione abundance and ferroptosis sensitivity, Cell Rep, 26, 1544, 10.1016/j.celrep.2019.01.043

Bachhawat, 2017, Glutathione degradation, Antioxid Redox Signal, 27, 1200, 10.1089/ars.2017.7136

Chen, 2017, CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway, Oncotarget, 8, 114588, 10.18632/oncotarget.23055

Wang, 2019, Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in burkitt's lymphoma, Biochem Biophys Res Commun, 519, 533, 10.1016/j.bbrc.2019.09.023

Shen, 2020, Resibufogenin (RB) inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation, Anat Rec., 10.1002/ar.24378

Hangauer, 2017, Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition, Nature, 551, 247, 10.1038/nature24297

Yoo, 2012, Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain, Free Radic Biol Med, 52, 1820, 10.1016/j.freeradbiomed.2012.02.043

Dalton, 2000, Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous, Biochem Biophys Res Commun, 279, 324, 10.1006/bbrc.2000.3930

Doll, 2019, FSP1 is a glutathione-independent ferroptosis suppressor, Nature, 575, 693, 10.1038/s41586-019-1707-0

Bersuker, 2019, The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis, Nature, 575, 688, 10.1038/s41586-019-1705-2

Doll, 2017, ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition, Nat Chem Biol, 13, 91, 10.1038/nchembio.2239

Badgley, 2020, Cysteine depletion induces pancreatic tumor ferroptosis in mice, Science, 368, 85, 10.1126/science.aaw9872

Magtanong, 2016, Emerging roles for lipids in non-apoptotic cell death, Cell Death Differ, 23, 1099, 10.1038/cdd.2016.25

Lewis-Wambi, 2008, Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis, Breast Cancer Res, 10, R104, 10.1186/bcr2208

Ramos, 2008, Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines, Biochem Pharmacol, 75, 1912, 10.1016/j.bcp.2008.02.007

Lv, 2019, Unraveling the potential role of glutathione in multiple forms of cell death in cancer therapy, Oxid Med Cell Longev, 2019, 3150145, 10.1155/2019/3150145

Harris, 2019, Deubiquitinases maintain protein homeostasis and survival of cancer cells upon glutathione depletion, Cell Metab, 29, 1166, 10.1016/j.cmet.2019.01.020